{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T12:20:34Z","timestamp":1699100434892},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1977,1,1]],"date-time":"1977-01-01T00:00:00Z","timestamp":220924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1977]]},"DOI":"10.1007\/bf00508817","type":"journal-article","created":{"date-parts":[[2004,11,17]],"date-time":"2004-11-17T12:17:01Z","timestamp":1100693821000},"page":"105-110","source":"Crossref","is-referenced-by-count":10,"title":["Irreversible binding of 3-14C-antipyrine to hepatic protein in vivo and in metabolizing liver microsomes"],"prefix":"10.1007","volume":"297","author":[{"given":"Sonja","family":"Tabarelli-Poplawski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Uehleke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.2042-7158.1973.tb09124.x","volume":"25","author":"J. D. Baty","year":"1973","unstructured":"Baty, J. D., Price Evans, D. A.: Norphenazone, a new metabolite of phenazone in human urine. J. Pharm. Pharmacol. 25, 83?84 (1973)","journal-title":"J. Pharm. Pharmacol."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0022-4731(74)90126-5","volume":"5","author":"H. M. Bolt","year":"1974","unstructured":"Bolt, H. M., Kappus, H.: Irreversible binding of ethynylestradiol metabolites to protein and nucleic acids as catalysed by rat liver microsomes and mushroom tyrosinase. J. Steroid Biochem. 5, 179?184 (1974)","journal-title":"J. Steroid Biochem."},{"key":"CR3","first-page":"97","volume":"98","author":"B. B. Brodie","year":"1950","unstructured":"Brodie, B. B., Axelrod, J.: The fate of antipyrine in man. J. Pharmacol. exp. Ther. 98, 97?104 (1950a)","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR4","first-page":"171","volume":"99","author":"B. B. Brodie","year":"1950","unstructured":"Brodie, B. B., Axelrod, J.: The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J. Pharmacol. exp. Ther. 99, 171?184 (1950b)","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/BF01946135","volume":"28","author":"J. W. Daly","year":"1972","unstructured":"Daly, J. W., Jerina, D. M., Witkop, B.: Arene oxide and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia (Basel) 28, 1129?1149 (1972)","journal-title":"Experientia (Basel)"},{"key":"CR6","first-page":"R 63","volume":"293","author":"M. Eichelbaum","year":"1976","unstructured":"Eichelbaum, M., Schomerus, M., Spannbrucker, N., Zietz, E.: The physiological disposition of 14C-antipyrine in man. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, R 63 (1976)","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01858558","volume":"177","author":"H. Erlenmeyer","year":"1935","unstructured":"Erlenmeyer, H., Berger, E.: \u00dcber immunchemische Untersuchungen in der Pyrazolonreihe. Naunyn-Schmiedebergs Arch exp. Path. Pharmak. 177, 116?118 (1935)","journal-title":"Naunyn-Schmiedebergs Arch exp. Path. Pharmak."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/bchm2.1950.285.1-3.97","volume":"285","author":"J. Halberkann","year":"1950","unstructured":"Halberkann, J., Fretwurst, F.: Die Stoffwechselprodukte des Pyramidons und verwandter Verbindungen beim Menschen. Hoppe-Seylers Z. physiol. Chem. 285, 97?127 (1950)","journal-title":"Hoppe-Seylers Z. physiol. Chem."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF01747175","volume":"44","author":"W. Hartl","year":"1966","unstructured":"Hartl, W., Puxeddu, A.: Zur Frage der Spezifit\u00e4t arzneimittelallergischer Immunreaktionen durch aminophenazonhaltige Antirheumatica. Klin. Wschr. 44, 30?32 (1966)","journal-title":"Klin. Wschr."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1248\/cpb.23.1889","volume":"23","author":"S. Iguchi","year":"1975","unstructured":"Iguchi, S., Goromary, T., Noda, A., Tsubone, N.: Excretion of 4-formylaminoantipyrine as a new metabolite of aminopyrine in experimental animals. Chem. pharm. Bull. 23, 1889?1890 (1975)","journal-title":"Chem. pharm. Bull."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-2952(76)90289-6","volume":"25","author":"M. O. James","year":"1976","unstructured":"James, M. O., Fouts, J. R., Bend, J. R.: Hepatic and extrahepatic metabolism in vitro, of an epoxide (8-14C-styrene oxide) in the rabbit. Biochem. Pharmacol. 25, 187?193 (1976)","journal-title":"Biochem. Pharmacol."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/257134a0","volume":"257","author":"H. Kappus","year":"1975","unstructured":"Kappus, H., Bolt, H. M., Buchter, A., Bolt, W.: Rat liver microsomes catalyse covalent binding of 14C-vinyl chloride to macromolecules. Nature (Lond.) 257, 134?135 (1975)","journal-title":"Nature (Lond.)"},{"key":"CR13","unstructured":"Klimek, F.: Untersuchungen zur Reaktivit\u00e4t von 1-Phenyl-3-methyl-pyrazolin-4,5-dion einem Metaboliten im Stoffwechsel der Pyrazolonk\u00f6rper. Diplomarbeit, Fachbereich Chemie, Universit\u00e4t T\u00fcbingen 1973"},{"key":"CR14","first-page":"989","volume":"3","author":"C. C. Magis","year":"1968","unstructured":"Magis, C. C., Barge, A., Dausset, J.: Serological studies of an allergic agranulocytosis due to noramidopyrine. Clin. exp. Immunol. 3, 989?1003 (1968)","journal-title":"Clin. exp. Immunol."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/0006-2952(75)90373-1","volume":"24","author":"M. Metzler","year":"1975","unstructured":"Metzler, M.: Metabolic activation of diethylstilbestrol: Indirect evidence for the formation of a stilbene oxide intermediate in hamster and rat. Biochem. Pharmacol. 24, 1449?1453 (1975)","journal-title":"Biochem. Pharmacol."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1042\/bj0550416","volume":"55","author":"F. Nash","year":"1953","unstructured":"Nash, F.: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55, 416?421 (1953)","journal-title":"Biochem. J."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/00498257309151525","volume":"2","author":"F. Oesch","year":"1973","unstructured":"Oesch, F.: Mammalian epoxide hydrase: inducible enzymes catalizing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 2, 305?340 (1973)","journal-title":"Xenobiotica"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1515\/bchm2.1971.352.2.1048","volume":"352","author":"O. Reiner","year":"1971","unstructured":"Reiner, O., Uehleke, H.: Bindung von Tetrachlorkohlenstoff an reduziertes mikrosomales Cytochrom P-450 und an H\u00e4m. Hoppe-Seylers Z. physiol. Chem. 352, 1048?1052 (1971)","journal-title":"Hoppe-Seylers Z. physiol. Chem."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00544847","volume":"255","author":"R. Sch\u00fcppel","year":"1966","unstructured":"Sch\u00fcppel, R.: Die Stickstoffdemethylierung am Phenazon (Antipyrin). Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 255, 71?72 (1966)","journal-title":"Naunyn-Schmiedebergs Arch. Pharmak. exp. Path."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00538008","volume":"260","author":"R. Sch\u00fcppel","year":"1968","unstructured":"Sch\u00fcppel, R.: Nachweis eines neuen reaktionsf\u00e4higen Metaboliten im Stoffwechsel von Phenazon (Antipyrin). Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 219?220 (1968a)","journal-title":"Naunyn-Schmiedebergs Arch. Pharmak. exp. Path."},{"key":"CR21","unstructured":"Sch\u00fcppel, R.: Pharmakokinetische Untersuchungen an der alkoholisierten Ratte. Dissertation, Math.-nat. Fakult\u00e4t, Universit\u00e4t T\u00fcbingen 1968 b"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00498257209111074","volume":"2","author":"H. Shimeno","year":"1972","unstructured":"Shimeno, H., Yoshimura, H.: Possible implication of a aldehyde metabolite in aminopyrine allergy. Xenobiotica 2, 461?468 (1972)","journal-title":"Xenobiotica"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-230X(08)60111-6","volume":"20","author":"P. Sims","year":"1974","unstructured":"Sims, P., Grover, P. L.: Epoxides in polycyclic aromatic hydrocarbons metabolism carcinogenesis. Advanc. Cancer Res. 20, 165?274 (1974)","journal-title":"Advanc. Cancer Res."},{"key":"CR24","first-page":"593","volume":"8","author":"M. Stafford","year":"1974","unstructured":"Stafford, M., Kellermann, G., Stillwell, R. N., Horning, M. G.: Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human. Res. Comm. Chem. Path. Pharmacol. 8, 593?605 (1974)","journal-title":"Res. Comm. Chem. Path. Pharmacol."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0028-1111046","volume":"89","author":"S. Thierfelder","year":"1964","unstructured":"Thierfelder, S., Magis, C., Saint-Paul, M., Dausset, J.: Die Pyramidon-Agranulocytose. Dtsch. med. Wschr. 89, 506?512 (1964)","journal-title":"Dtsch. med. Wschr."},{"key":"CR26","first-page":"447","volume":"123","author":"H. Uehleke","year":"1962","unstructured":"Uehleke, H.: Biochemische Reaktionen als Ursache erworbener \u00dcberempfindlichkeit gegen Fremdstoffe. Z. Immun.-Forsch. 123, 447?457 (1962)","journal-title":"Z. Immun.-Forsch."},{"issue":"Suppl.","key":"CR27","first-page":"22","volume":"1","author":"H. Uehleke","year":"1974","unstructured":"Uehleke, H.: Metabolite von Arznei- und Fremdstoffen als Allergene. Z. Immun-Forsch. 1 (Suppl.), 22?36 (1974)","journal-title":"Z. Immun-Forsch."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00498257309151495","volume":"3","author":"H. Uehleke","year":"1973","unstructured":"Uehleke, H., Hellmer, K. H., Tabarelli, S.: Binding of 14C-carbon tetrachloride to microsomal proteins in vitro and formation of CHCl3 by reduced liver microsomes. Xenobiotica 3, 1?11 (1973a)","journal-title":"Xenobiotica"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00502066","volume":"279","author":"H. Uehleke","year":"1973","unstructured":"Uehleke, H., Hellmer, K. H., Tabarelli-Poplawski, S.: Metabolic activation of halothane and its covalent binding to liver endoplasmatic proteins in vitro. Naunyn-Schmiedebergs Arch. Pharmacol. 279, 39?52 (1973b)","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"CR30","doi-asserted-by":"crossref","unstructured":"Uehleke, H., Tabarelli-Poplawski, S., Bonse, G., Henschler, D.: Spectral evidence for 2,2,3-trichloro-oxirane formation during microsomal trichloroethylene oxidation. Arch. Toxicol. (in press, 1977)","DOI":"10.1007\/BF00293858"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0006-2952(75)90445-1","volume":"24","author":"T. Watabe","year":"1975","unstructured":"Watabe, T., Yamada, N.: The biotransformation of 1-hexadecene to carcinogenic 1,2-epoxyhexadecane by hepatic microsomes. Biochem. Pharmacol. 24, 1051?1053 (1975)","journal-title":"Biochem. Pharmacol."},{"key":"CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1248\/cpb.19.41","volume":"19","author":"H. Yoshimura","year":"1971","unstructured":"Yoshimura, H., Shimeno, H., Tsukamoto, H.: Metabolism of drugs. LXX, Further study on antipyrine metabolism. Chem. pharm. Bull. 19, 41?45 (1971)","journal-title":"Chem. pharm. Bull."}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00508817.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00508817\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00508817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T18:17:09Z","timestamp":1554401829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00508817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1977]]}},"alternative-id":["BF00508817"],"URL":"https:\/\/doi.org\/10.1007\/bf00508817","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977]]}}}